(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 8.59% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.99%.
Inspire Medical Systems's revenue in 2026 is $911,981,000.On average, 20 Wall Street analysts forecast INSP's revenue for 2026 to be $28,162,738,778, with the lowest INSP revenue forecast at $26,473,683,466, and the highest INSP revenue forecast at $29,389,791,148. On average, 19 Wall Street analysts forecast INSP's revenue for 2027 to be $30,447,594,915, with the lowest INSP revenue forecast at $27,793,365,139, and the highest INSP revenue forecast at $32,477,434,576.
In 2028, INSP is forecast to generate $33,563,827,634 in revenue, with the lowest revenue forecast at $29,847,219,804 and the highest revenue forecast at $37,537,739,083.